QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
Fang C, Zhou Y, Feng Y, He L, Yu J, Li Y, Feng M, Pan M, Zhao L, Tang D, Li X, Tan B, An R, Zheng X, Si M, Zhang B, Li L, Kang X, Zhou Q, Liu J.
Fang C, et al. Among authors: si m.
J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.35.e77. Online ahead of print.
J Gynecol Oncol. 2024.
PMID: 38606822
Free article.